Skip to main content

Advertisement

Log in

The ocular manifestations of relapsing polychondritis

  • Original Paper
  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

Relapsing polychondritis (RPC) is a rare, multi-system, inflammatory disorder. Ocular disease is estimated to occur in 14–67% of patients with RPC, and any ocular structure can be affected. Published case reports and series of RPC were analysed to determine the frequency and nature of the ocular manifestations of RPC, including the age and gender distribution.

Methods

A literature search of the MEDLINE database for case reports and series on RPC was conducted in October 2021 using search terms [relapsing polychondritis (MeSH Major Topic)] OR [relapsing polychondritis (Title/Abstract)]. Articles were included if the diagnosis of RPC was confirmed using established diagnostic criteria and if the paper described the clinical features of patients with RPC.

Results

546 articles (454 case reports and 92 case series) described the clinical features in a total of 2414 patients with RPC.

49% of patients with RPC had ocular involvement, and this was a presenting feature in 21%. The most common ocular manifestations were scleritis (32%), episcleritis (31%) and uveitis (23%).

Conclusion

Many patients with RPC will be seen by an ophthalmologist during the course of their disease. Knowledge and awareness of RPC and its ocular manifestations is therefore essential to enable the ophthalmologist to make the diagnosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Borgia F, Giuffrida R, Guarneri F et al (2018) Relapsing polychondritis: an updated review. Biomedicines 6(3):84

    Article  PubMed  PubMed Central  Google Scholar 

  2. Kumakiri K, Sakamoto T, Karahashi T et al (2005) A case of relapsing polychondritis preceded by inner ear involvement. Auris Nasus Larynx 32(1):71–76

    Article  PubMed  Google Scholar 

  3. Stabler T, Piette J-C, Chevalier X et al (2004) Serum cytokine profiles in relapsing polychondritis suggest monocyte/macrophage activation. Arthritis Rheum 50(11):3663–3667

    Article  CAS  PubMed  Google Scholar 

  4. Valenzuela R, Cooperrider PA, Gogate P et al (1980) Relapsing polychondritis. Hum Pathol 11(1):19–22

    Article  CAS  PubMed  Google Scholar 

  5. Arnaud L, Mathian A, Haroche J et al (2014) Pathogenesis of relapsing polychondritis: a 2013 update. Autoimmun Rev 13(2):90–95

    Article  CAS  PubMed  Google Scholar 

  6. Yang CL, Brinckmann J, Rui HF et al (1993) Autoantibodies to cartilage collagens in relapsing polychondritis. Arch Dermatol Res 285(5):245–249

    Article  CAS  PubMed  Google Scholar 

  7. Trentham DE, Le CH (1998) Relapsing polychondritis. Ann Intern Med 129(2):114–122

    Article  CAS  PubMed  Google Scholar 

  8. Michet CJ, McKenna CH, Luthra HS et al (1986) Relapsing polychondritis. Ann Intern Med 104(1):74–78

    Article  PubMed  Google Scholar 

  9. McAdam LP, O’Hanlan MA, Bluestone R et al (1976) Relapsing polychondritis: prospective study of 23 patients and a review of the literature. Medicine (Baltimore) 55(3):193–215

    Article  CAS  PubMed  Google Scholar 

  10. Damiani JM, Levine HL (1979) Relapsing polychondritis—report of ten cases. Laryngoscope 89(6):929–946

    CAS  PubMed  Google Scholar 

  11. Arnaud L, Devilliers H, Peng SL et al (2012) The Relapsing Polychondritis Disease Activity Index: development of a disease activity score for relapsing polychondritis. Autoimmun Rev 12(2):204–209

    Article  PubMed  Google Scholar 

  12. Choy EHS, Chikanza IC, Kinglsey GH et al (1991) Chimaeric anti-CD4 monoclonal antibody for relapsing polychondritis. Lancet 338(8764):450

    Article  CAS  PubMed  Google Scholar 

  13. Lubbe PVD, Miltenburg A, Breedveld F (1991) Anti-CD4 monoclonal antibody for relapsing polychondritis. Lancet 337(8753):1349

    Article  PubMed  Google Scholar 

  14. Koenig AS, Abruzzo JL (2002) Leflunomide induced fevers, thrombocytosis, and leukocytosis in a patient with relapsing polychondritis. J Rheumatol 29(1):192–194

    PubMed  Google Scholar 

  15. Moulis G, Pugnet G, Costedoat-Chalumeau N et al (2018) Efficacy and safety of biologics in relapsing polychondritis: a French National Multicentre Study. Ann Rheum Dis 77(8):1172–1178

    CAS  PubMed  Google Scholar 

  16. Pfister R, Messe M, Niclauss L et al (2019) 18-fluorodeoxyglucose positron emission tomography–computed tomography to guide aortic arch replacement in relapsing polychondritis. Aorta 7(01):018–021

    Article  Google Scholar 

  17. Peng SL, Rodriguez D (2013) Abatacept in relapsing polychondritis. Ann Rheum Dis 72(8):1427–1429

    Article  CAS  PubMed  Google Scholar 

  18. Dion J, Costedoat-Chalumeau N, Sène D et al (2016) Relapsing polychondritis can be characterized by three different clinical phenotypes: analysis of a recent series of 142 patients. Arthritis Rheumatol 68(12):2992–3001

    Article  PubMed  Google Scholar 

  19. Zheutlin A, Schiopu E (2018) Relapsing polychondritis following treatment with secukinumab for ankylosing spondylitis: case report and review of the literature. Case Rep Rheumatol 2018

  20. Hazra N, Dregan A, Charlton J et al (2015) Incidence and mortality of relapsing polychondritis in the UK: a population-based cohort study. Rheumatology 54(12):2181–2187

    PubMed  Google Scholar 

  21. de la Maza MS, Jabbur NS, Foster CS (1994) Severity of scleritis and episcleritis. Ophthalmology 101(2):389–396

    Article  Google Scholar 

  22. Braithwaite T, Adderley NJ, Subramanian A et al (2021) Epidemiology of scleritis in the United Kingdom from 1997 to 2018: population-based analysis of 11 million patients and association between scleritis and infectious and immune-mediated inflammatory disease. Arthritis Rheumatol 73(7):1267–1276

    Article  PubMed  Google Scholar 

  23. Kong K, Vasoo S, Tay N et al (2003) Relapsing polychondritis-an oriental case series. Singap Med J 44(4):197–200

    CAS  Google Scholar 

  24. Chen N, Zheng Y (2021) Characteristics and clinical outcome of 295 patients with relapsing polychondritis. J Rheumatol (Internet). https://www.jrheum.org/content/early/2021/07/25/jrheum.210062. (Cited 26 Nov 2021

  25. Ferrada M, Rimland CA, Quinn K et al (2020) Defining clinical subgroups in relapsing polychondritis: a prospective observational cohort study. Arthritis Rheumatol 72(8):1396–1402

    Article  PubMed  PubMed Central  Google Scholar 

  26. Shimizu J, Yamano Y, Kawahata K et al (2020) Elucidation of predictors of disease progression in patients with relapsing polychondritis at the onset: potential impact on patient monitoring. BMC Rheumatol 4(1):41

    Article  PubMed  PubMed Central  Google Scholar 

  27. Isaak BL, Liesegang TJ, Michet CJ (1986) Ocular and systemic findings in relapsing polychondritis. Ophthalmology 93(5):681–689

    Article  CAS  PubMed  Google Scholar 

  28. Hoang-Xuan T, Foster CS, Rice BA (1990) Scleritis in relapsing polychondritis: response to therapy. Ophthalmology 97(7):892–898

    Article  Google Scholar 

  29. Paroli M, Priori R, Spinucci G et al (2012) Case report uveitis with retinal occlusive vasculitis and sensorineural hypoacusia as first symptoms of relapsing polychondritis. Clin Exp Rheumatol 30(1 Suppl 70):S101–S103

    PubMed  Google Scholar 

  30. Van Besien K, Tricot G, Hoffman R (1992) Relapsing polychondritis: a paraneoplastic syndrome associated with myelodysplastic syndromes. Am J Hematol 40(1):47–50

    Article  PubMed  Google Scholar 

  31. Abrahamsen AM, Bergaust B (1969) Relapsing polychondritis. Acta Med Scand 185(1–6):175–178

    CAS  PubMed  Google Scholar 

  32. Sakuta T, Morita Y, Sakai J et al (2005) A case of Vogt–Koyanagi–Harada disease that developed relapsing polychondritis. Mod Rheumatol 15(3):204–206

    Article  PubMed  Google Scholar 

  33. Lee SMS, Fan BE, Lim JH-L et al (2021) A case of VEXAS syndrome manifesting as Kikuchi-Fujimoto disease, relapsing polychondritis, venous thromboembolism and macrocytic anaemia. Rheumatology 60(9):e304-6

    Article  PubMed  Google Scholar 

  34. Ellen NY, Jurkunas U, Rubin PA et al (2006) Obliterative microangiopathy presenting as chronic conjunctivitis in a patient with relapsing polychondritis. Cornea 25(5):621–622

    Article  Google Scholar 

  35. Firestein GS, Gruber HE, Weisman MH et al (1985) Mouth and genital ulcers with inflamed cartilage: MAGIC syndrome. Five patients with features of relapsing polychondritis and Behçet’s disease. Am J Med. 79(1):65–72

    Article  CAS  PubMed  Google Scholar 

  36. Peebo BB, Peebo M, Frennesson C (2004) Relapsing polychondritis: a rare disease with varying symptoms. Acta Ophthalmol Scand 82(4):472–475

    Article  PubMed  Google Scholar 

  37. Yang P, Yuan W, Du L et al (2019) Clinical features of Chinese patients with relapsing polychondritis. Br J Ophthalmol 103(8):1129–1132

    Article  PubMed  Google Scholar 

  38. He Y, Liu H, Ji Z, Zhu B (2017) Surgical interventions for late ocular complications of relapsing polychondritis. Am J Ophthalmol Case Rep 5:63–66

    Article  PubMed  Google Scholar 

  39. Anderson B (1967) Ocular lesions in relapsing polychondritis and other rheumatoid syndromes: the Edward Jackson memorial lecture. Am J Ophthalmol 64(1):35–50

    Article  CAS  PubMed  Google Scholar 

  40. Ridgway HB, Hansotia PL, Schorr WF (1979) Relapsing polychondritis: unusual neurological findings and therapeutic efficacy of dapsone. Arch Dermatol 115(1):43–45

    Article  CAS  PubMed  Google Scholar 

  41. Brink H, Rademakers J, Verbeek A et al (1994) Ocular manifestations of relapsing polychondritis. Doc Ophthalmol 87(2):159–166

    Article  CAS  PubMed  Google Scholar 

  42. Hirunwiwatkul P, Trobe JD (2007) Optic neuropathy associated with periostitis in relapsing polychondritis. J Neuroophthalmol 27(1):16–21

    Article  PubMed  Google Scholar 

  43. Ikeda T, Yoshida T, Yamamoto H et al (2021) Sequential involvement of oculomotor nerve and optic nerve sheath in relapsing polychondritis. J Neuroophthalmol. https://doi.org/10.1097/WNO.0000000000001321

    Article  PubMed  Google Scholar 

  44. Ahn S-W, Park M-S, Jeong H-B et al (2017) Relapsing polychondritis presented with encephalitis followed by brain atrophy. Exp Neurobiol 26(1):66

    Article  PubMed  Google Scholar 

  45. Miura Y, Fukuda K, Taniguchi Y et al (2019) Recurrent optic perineuritis as the first manifestation of relapsing polychondritis. J Neuroophthalmol 39(4):513–514

    Article  PubMed  Google Scholar 

  46. Wang Z, Pu C, Zhang J et al (2011) Meningoencephalitis or meningitis in relapsing polychondritis: four case reports and a literature review. J Clin Neurosci 18(12):1608–1615

    Article  CAS  PubMed  Google Scholar 

  47. Nara M, Komatsuda A, Togashi M et al (2015) Relapsing polychondritis with encephalitis: a case report and literature review. Intern Med 54(2):231–234

    Article  PubMed  Google Scholar 

  48. Coha B, Fustar-Preradovic L, Sekelj S et al (2007) Total hearing loss and blindness caused by relapsing polychondritis and myelodysplastic syndrome. Eur Arch Otorhinolaryngol 264(12):1517–1519

    Article  PubMed  Google Scholar 

  49. Eun YH, Seok H, Shin IS et al (2016) Relapsing polychondritis presenting with inflammatory pseudotumor. Korean J Intern Med 31(5):1003–1005

    Article  PubMed  PubMed Central  Google Scholar 

  50. Wang C-R, Hsu S-M, Chen Y-C et al (2019) Idiopathic sclerosing orbital inflammation in a relapsing polychondritis patient with impaired vision. J Clin Rheumatol 25(6):e82–e83

    Article  PubMed  Google Scholar 

  51. Crovato F, Nigro A, Marchi RD et al (1980) Exophthalmos in relapsing polychondritis. Arch Dermatol 116(4):383–384

    Article  CAS  PubMed  Google Scholar 

  52. Lichauco JJ, Lauer S, Shigemitsu HH et al (2001) Orbital mucosa-associated lymphoid tissue (MALT)–type lymphoma in a patient with relapsing polychondritis. Arthritis Rheum 44(7):1713–1715

    Article  CAS  PubMed  Google Scholar 

  53. Hosseini SM, Shirzad S, Ghasemi M (2019) Bilateral panuveitis and keratitis as first presentation of relapsing polychondritis. Ocul Immunol Inflamm 27(8):1267–1269

    Article  PubMed  Google Scholar 

  54. Sundaram M, Rajput A (1983) Nervous system complications of relapsing polychondritis. Neurology 33(4):513–513

    Article  CAS  PubMed  Google Scholar 

  55. Topalkara K, Kaptanoglu E, Akyüz A et al (2003) Relapsing polychondritis with involvement of posterior inferior cerebellar artery causing acute lateral medullary syndrome. JCR J Clin Rheumatol 9(2):92–95

    Article  CAS  PubMed  Google Scholar 

  56. Brod S, Booss J (1988) Idiopathic CSF pleocytosis in relapsing polychondritis. Neurology 38(2):322–322

    Article  CAS  PubMed  Google Scholar 

  57. Neild G, Cameron J, Lessof M et al (1978) Relapsing polychondritis with crescentic glomerulonephritis. Br Med J 1(6115):743–745

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Fairweather D, Frisancho-Kiss S, Rose NR (2008) Sex differences in autoimmune disease from a pathological perspective. Am J Pathol 173(3):600–609

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Foxman EF, Zhang M, Hurst SD et al (2002) Inflammatory mediators in uveitis: differential induction of cytokines and chemokines in Th1- versus Th2-mediated ocular inflammation. J Immunol 168(5):2483–2492

    Article  CAS  PubMed  Google Scholar 

  60. Ooi KG-J, Galatowicz G, Calder VL et al (2006) Cytokines and chemokines in uveitis: is there a correlation with clinical phenotype? Clin Med Res 4(4):294–309

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Thanks go to Anne Williams and Sorrell Williams from the Royal Glamorgan Hospital library for their help in obtaining articles and to Nigel Davies and Claire Gallagher for their proof reading assistance.

Funding

The authors declare that no funds, grants, or other support were received during the preparation of this manuscript.

Author information

Authors and Affiliations

Authors

Contributions

KG and AA-J contributed to the study conception and design. All authors contributed to data collection and analysis. The first draft of the manuscript was written by KG, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Kevin Gallagher.

Ethics declarations

Conflict of interest

The authors have no relevant financial or non-financial interests to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 496 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gallagher, K., Al-Janabi, A. & Wang, A. The ocular manifestations of relapsing polychondritis. Int Ophthalmol 43, 2633–2641 (2023). https://doi.org/10.1007/s10792-023-02662-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10792-023-02662-w

Keywords

Navigation